Search research articles
Contact Us
Filters
Showing results (81-90 of 149) with videos related to
Page
of 15
Sort By:
Annals of Hematology
|
May 25, 2012
Cell surface expression of CD25 antigen (surface IL-2 receptor α-chain) is not a prognostic marker in chronic lymphocytic leukemia: results of a retrospective study of 281 patients
Lev Shvidel, Andrei Braester, Osnat Bairey, et al.
Cancer
|
August 12, 2022
Impact of acupuncture and integrative therapies on chemotherapy-induced peripheral neuropathy: A multicentered, randomized controlled trial
Eran Ben-Arye, David Hausner, Noah Samuels, et al.
Leukemia Research
|
February 12, 2013
Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas
Alessia Bari, Tamar Tadmor, Stefano Sacchi, et al.
Frontiers in Immunology
|
March 1, 2021
The Role of Alpha 2 Macroglobulin in IgG-Aggregation and Chronic Activation of the Complement System in Patients With Chronic Lymphocytic Leukemia
Naseba Naseraldeen, Regina Michelis, Masad Barhoum, et al.
International Journal of Molecular Sciences
|
January 11, 2024
The Involvement of LAG-3<sup>positive</sup> Plasma Cells in the Development of Multiple Myeloma
Natalia Kreiniz, Nasren Eiza, Tamar Tadmor, et al.
Anticancer Research
|
February 11, 2014
Hodgkin's variant of Richter transformation in chronic lymphocytic leukemia; a retrospective study from the Israeli CLL study group
Tamar Tadmor, Lev Shvidel, Neta Goldschmidt, et al.
Scientific Reports
|
November 5, 2025
Virtual reality and hypnosis for symptom alleviation before bone marrow procedure
Ilana Levy Yurkovski, Dina Libes, Maya Meiseles, et al.
Hematological Oncology
|
February 14, 2019
Low-dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD-FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experience
Yair Herishanu, Tamar Tadmor, Andrei Braester, et al.
Blood
|
December 3, 2021
Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination
Yair Herishanu, Galia Rahav, Shai Levi, et al.
American Journal of Hematology
|
August 12, 2014
Richter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group
Tamar Tadmor, Lev Shvidel, Osnat Bairey, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 149) with videos related to
Sort By:
Page
of 15
Annals of Hematology
|
May 25, 2012
Cell surface expression of CD25 antigen (surface IL-2 receptor α-chain) is not a prognostic marker in chronic lymphocytic leukemia: results of a retrospective study of 281 patients
Lev Shvidel, Andrei Braester, Osnat Bairey, et al.
Cancer
|
August 12, 2022
Impact of acupuncture and integrative therapies on chemotherapy-induced peripheral neuropathy: A multicentered, randomized controlled trial
Eran Ben-Arye, David Hausner, Noah Samuels, et al.
Leukemia Research
|
February 12, 2013
Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas
Alessia Bari, Tamar Tadmor, Stefano Sacchi, et al.
Frontiers in Immunology
|
March 1, 2021
The Role of Alpha 2 Macroglobulin in IgG-Aggregation and Chronic Activation of the Complement System in Patients With Chronic Lymphocytic Leukemia
Naseba Naseraldeen, Regina Michelis, Masad Barhoum, et al.
International Journal of Molecular Sciences
|
January 11, 2024
The Involvement of LAG-3<sup>positive</sup> Plasma Cells in the Development of Multiple Myeloma
Natalia Kreiniz, Nasren Eiza, Tamar Tadmor, et al.
Anticancer Research
|
February 11, 2014
Hodgkin's variant of Richter transformation in chronic lymphocytic leukemia; a retrospective study from the Israeli CLL study group
Tamar Tadmor, Lev Shvidel, Neta Goldschmidt, et al.
Scientific Reports
|
November 5, 2025
Virtual reality and hypnosis for symptom alleviation before bone marrow procedure
Ilana Levy Yurkovski, Dina Libes, Maya Meiseles, et al.
Hematological Oncology
|
February 14, 2019
Low-dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD-FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experience
Yair Herishanu, Tamar Tadmor, Andrei Braester, et al.
Blood
|
December 3, 2021
Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination
Yair Herishanu, Galia Rahav, Shai Levi, et al.
American Journal of Hematology
|
August 12, 2014
Richter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group
Tamar Tadmor, Lev Shvidel, Osnat Bairey, et al.
Page
of 15